Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Director/PDMR Shareholding

27 Sep 2017 16:59

RNS Number : 0162S
Cello Group plc
27 September 2017
 

27 September 2017

Cello Group plc

 ("Cello" or the "Company")

 

Director/PDMR Shareholding

 

The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to transfer the Ordinary Shares to Mr Bentley's SIPP. The sale price was 127.50 pence per share and the purchase price was 127.53 pence per share.

The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Bentley and, following this transaction, Mr Bentley remains beneficially and non-beneficially interested in 442,518 Ordinary Shares, representing approximately 0.4 per cent. of the Company's issued ordinary share capital.

The Company has also received notification that on 27 September 2017, Jane Shirley, a director of Cello Health, exercised share options over 20,000 Ordinary Shares for an exercise price of 10 pence per share, and subsequently sold the 20,000 Ordinary Shares for a price of 127 pence per share. In addition, on 26 September 2017, Alistair Shirley, a person closely associated with Jane Shirley, sold 421 Ordinary Shares at a price of 129 pence per share.

Following the above transactions, Jane Shirley and her persons closely associated hold 78,000 Ordinary Shares, representing approximately 0.1% of the Company's issued ordinary share capital.

 

Enquiries:

 

Cello Group

020 7812 8460

Mark Scott, Chief Executive

Mark Bentley, Finance Director

Cenkos Securities

0207 397 8900

Bobbie Hilliam

Harry Hargreaves

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.50p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,250

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127.53p

110,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

110,000

 

£140,283

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

10p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£2,000

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

Outside trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Jane Shirley

2

Reason for the notification

a)

Position/status

Director of Cello Health

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

127p

20,000

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

20,000

 

£25,400

e)

Date of the transaction

27 September 2017

f)

Place of the transaction

XLON

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Alistair Shirley

2

Reason for the notification

a)

Position/status

Person closely associated with Jane Shirley

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Group plc

b)

LEI

2138004TZYGZLWQP7N64

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 10p each

 

 

GB00B0310763

b)

Nature of the transaction

Sale of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

129p

421

d)

Aggregated information

 

-Aggregated volume

 

-Price

 

 

421

 

£543.09

e)

Date of the transaction

26 September 2017

f)

Place of the transaction

XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUBVVRBWAKUAR
Date   Source Headline
20th Jul 202012:21 pmRNSForm 8.3 - Cello Health Plc
17th Jul 20209:14 amRNSForm 8.3 - Cello Health PLC
16th Jul 20205:00 pmRNSForm 8.3 - Cello Health plc
16th Jul 20208:48 amRNSForm 8.3 - Cello Health PLC
16th Jul 20207:00 amRNSForm 8.3 - Cello Health Plc
15th Jul 20203:00 pmRNSUpdate re: antitrust clearances
15th Jul 20201:44 pmRNSForm 8.3 - Cello Health Plc
15th Jul 20201:21 pmRNSHolding(s) in Company
15th Jul 20208:55 amRNSForm 8.3 - Cello Health PLC
14th Jul 20201:33 pmRNSForm 8.3 - Cello Health plc
14th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
14th Jul 20208:04 amRNSHolding(s) in Company
14th Jul 20207:01 amRNSHolding(s) in Company
13th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
13th Jul 202010:51 amBUSForm 8.3 - CELLO HEALTH PLC
13th Jul 20208:18 amRNSForm 8.3 - Cello Health PLC
13th Jul 20207:00 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSPublication of Scheme Document
10th Jul 20203:20 pmRNSForm 8.3 - Cello Health Plc
10th Jul 20203:17 pmRNSForm 8.3 - Cello Health PLC
10th Jul 20203:10 pmPRNForm 8.3 - Cello Health Plc
10th Jul 20201:34 pmBUSForm 8.3 - CELLO HEALTH PLC
10th Jul 202010:11 amRNSHolding(s) in Company
10th Jul 20209:41 amRNSForm 8.3 - Cello Health Plc
10th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
9th Jul 20206:20 pmRNSUpdate on letters of intent
9th Jul 20205:38 pmRNSHolding(s) in Company
9th Jul 20203:20 pmRNSForm 8.3 - Cello Health
9th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
9th Jul 20203:08 pmRNSForm 8.3 - Cello Health PLC
9th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
9th Jul 202012:33 pmRNSHolding(s) in Company
9th Jul 202011:31 amRNSForm 8.3 - Cello Health Plc
9th Jul 20209:20 amRNSForm 8.3 - Cello Health plc
9th Jul 20209:10 amRNSForm 8.3 - Cello Health PLC
9th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20203:56 pmPRNForm 8.3 - Cello Health Plc
8th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
8th Jul 20202:00 pmRNSForm 8.3 - Cello Health Plc
8th Jul 202012:45 pmRNSForm 8.3 - Cello Health plc
8th Jul 202010:35 amRNSForm 8.3 - Cello Health PLC
8th Jul 20209:55 amRNSForm 8.3 - Cello Health plc
8th Jul 20208:54 amPRNForm 8.3 - Cello Health plc
8th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
7th Jul 20203:20 pmRNSForm 8.3 - Cello Health
7th Jul 20203:19 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
7th Jul 202010:08 amRNSCELLO HEALTH PLC
7th Jul 20209:16 amPRNForm 8.3 - Cello Health Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.